MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 234 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,262,390 | -37.3% | 1,426,239 | -22.1% | 0.00% | -50.0% |
| Q2 2023 | $22,755,775 | -35.9% | 1,830,714 | -27.7% | 0.00% | -50.0% |
| Q1 2023 | $35,486,386 | +35.8% | 2,532,932 | +38.7% | 0.00% | +33.3% |
| Q4 2022 | $26,131,750 | -21.5% | 1,826,118 | +40.1% | 0.00% | -40.0% |
| Q3 2022 | $33,279,000 | -58.7% | 1,303,506 | -54.0% | 0.01% | -50.0% |
| Q2 2022 | $80,545,000 | -19.7% | 2,835,117 | -0.3% | 0.01% | -28.6% |
| Q1 2022 | $100,273,000 | -5.1% | 2,843,021 | +12.8% | 0.01% | +7.7% |
| Q4 2021 | $105,607,000 | -15.6% | 2,520,453 | -1.1% | 0.01% | -23.5% |
| Q3 2021 | $125,058,000 | +56.7% | 2,548,051 | +33.3% | 0.02% | +54.5% |
| Q2 2021 | $79,783,000 | +59.0% | 1,911,878 | +35.8% | 0.01% | +57.1% |
| Q1 2021 | $50,173,000 | +6643.7% | 1,407,795 | +5207.2% | 0.01% | – |
| Q4 2020 | $744,000 | – | 26,526 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
| Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
| Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
| Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
| Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
| Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
| Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
| Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
| STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
| Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |